{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:34:45Z","timestamp":1790616885689,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015544","name":"King's College Hospital Charity","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015544","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004791","name":"Target Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004791","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014381","name":"Advantage West Midlands","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014381","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005839","name":"Garden Club of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005839","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018955","name":"Leeds Biomedical Research Centre","doi-asserted-by":"publisher","award":["NIHR203331"],"award-info":[{"award-number":["NIHR203331"]}],"id":[{"id":"10.13039\/501100018955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012536","name":"Leeds Hospital Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012536","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000777","name":"University of Leeds","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000777","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1136\/ard-2024-225515","type":"journal-article","created":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T13:25:25Z","timestamp":1727961925000},"page":"329-340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Age, anticoagulants, hypertension and cardiovascular genetic traits predict cranial ischaemic complications in patients with giant cell arteritis"],"prefix":"10.1016","volume":"84","author":[{"given":"Natalie J.M.","family":"Chaddock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte J.","family":"Harden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Sorensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah R.","family":"Mathieson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Zulcinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A.","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eoin","family":"O'Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan P.","family":"Mollan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah L.","family":"Mackie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2603-6509","authenticated-orcid":false,"given":"Mark M.","family":"Iles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann W.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard-2024-225515_bib1","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1056\/NEJMcp1214825","article-title":"Clinical practice. Giant-cell arteritis and polymyalgia rheumatica","volume":"371","author":"Weyand","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1136\/ard-2024-225515_bib2","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/rheumatology\/kez672","article-title":"British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis","volume":"59","author":"Mackie","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard-2024-225515_bib3","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41572-021-00327-5","article-title":"Large-vessel vasculitis","volume":"7","author":"Pugh","year":"2022","journal-title":"Nat Rev Dis Primers"},{"key":"10.1136\/ard-2024-225515_bib4","doi-asserted-by":"crossref","first-page":"ii63","DOI":"10.1093\/rheumatology\/kex428","article-title":"Ophthalmic manifestations of giant cell arteritis","volume":"57","author":"Vodopivec","year":"2018","journal-title":"Rheumatol (Oxford)"},{"key":"10.1136\/ard-2024-225515_bib5","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1136\/ard-2023-223895","article-title":"Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients","volume":"82","author":"Monti","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2024-225515_bib6","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/rheumatology\/ken465","article-title":"Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis","volume":"48","author":"Salvarani","year":"2009","journal-title":"Rheumatology (Sunnyvale)"},{"key":"10.1136\/ard-2024-225515_bib7","article-title":"The association of vascular risk factors with visual loss in giant cell arteritis","volume":"56","author":"Yates","year":"2017","journal-title":"Rheumatology (Sunnyvale)"},{"key":"10.1136\/ard-2024-225515_bib8","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1093\/rheumatology\/ker265","article-title":"Ischaemic manifestations in giant cell arteritis are associated with area level socio-economic deprivation, but not cardiovascular risk factors","volume":"50","author":"Mackie","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard-2024-225515_bib9","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/01.md.0000180043.19285.54","article-title":"Giant cell arteritis: laboratory tests at the time of diagnosis in a series of 240 patients","volume":"84","author":"Gonzalez-Gay","year":"2005","journal-title":"Medicine (Balt)"},{"key":"10.1136\/ard-2024-225515_bib10","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.autrev.2014.02.006","article-title":"Effect of antiplatelet\/anticoagulant therapy on severe ischemic complications in patients with giant cell arteritis: A cumulative meta-analysis","volume":"13","author":"Mart\u00ednez-Taboada","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1136\/ard-2024-225515_bib11","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/art.20171","article-title":"Low\u2010dose aspirin and prevention of cranial ischemic complications in giant cell arteritis","volume":"50","author":"Nesher","year":"2004","journal-title":"Arthritis & Rheum"},{"key":"10.1136\/ard-2024-225515_bib12","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1002\/art.22141","article-title":"Antiplatelet and anticoagulant therapy in patients with giant cell arteritis","volume":"54","author":"Lee","year":"2006","journal-title":"Arthritis & Rheum"},{"key":"10.1136\/ard-2024-225515_bib13","first-page":"S57","article-title":"Impact of antiplatelet therapy in the development of severe ischemic complications and in the outcome of patients with giant cell arteritis","volume":"26","author":"Narv\u00e1ez","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard-2024-225515_bib14","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1136\/hrt.2004.037481","article-title":"Giant cell arteritis and cardiovascular disease in older adults","volume":"91","author":"Ray","year":"2005","journal-title":"Heart"},{"key":"10.1136\/ard-2024-225515_bib15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/rheumatology\/kev262","article-title":"Increased risk of cardiovascular disease in giant cell arteritis: a general population\u2013based study","volume":"55","author":"Amiri","year":"2016","journal-title":"Rheumatology (Sunnyvale)"},{"key":"10.1136\/ard-2024-225515_bib16","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1136\/heartjnl-2015-308514","article-title":"Associations between polymyalgia rheumatica and giant cell arteritis and 12 cardiovascular diseases","volume":"102","author":"Pujades-Rodriguez","year":"2016","journal-title":"Heart"},{"key":"10.1136\/ard-2024-225515_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003432","article-title":"Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort study","volume":"17","author":"Pujades-Rodriguez","year":"2020","journal-title":"PLoS Med"},{"key":"10.1136\/ard-2024-225515_bib18","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nature08185","article-title":"Common polygenic variation contributes to risk of schizophrenia and bipolar disorder","volume":"460","author":"Purcell","year":"2009","journal-title":"Nat New Biol"},{"key":"10.1136\/ard-2024-225515_bib19","first-page":"94","article-title":"Distribution of HLA-DRB1 alleles of patients with polymyalgia rheumatica and giant cell arteritis in a Mediterranean population","volume":"25","author":"Combe","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1136\/ard-2024-225515_bib20","first-page":"2148","article-title":"Mannose-binding lectin variant alleles and HLA-DR4 alleles are associated with giant cell arteritis","volume":"29","author":"Jacobsen","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1136\/ard-2024-225515_bib21","first-page":"2019","article-title":"Endothelial nitric oxide synthase haplotype associations in biopsy-proven giant cell arteritis","volume":"30","author":"Amoli","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1136\/ard-2024-225515_bib22","first-page":"1535","article-title":"Influence of interleukin 10 promoter polymorphisms in susceptibility to giant cell arteritis in Northwestern Spain","volume":"34","author":"Rueda","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1136\/ard-2024-225515_bib23","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ajhg.2016.11.013","article-title":"A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis","volume":"100","author":"Carmona","year":"2017","journal-title":"Am J Hum Genet"},{"key":"10.1136\/ard-2024-225515_bib24","doi-asserted-by":"crossref","DOI":"10.1093\/gigascience\/giz082","article-title":"PRSice-2: Polygenic Risk Score software for biobank-scale data","volume":"8","author":"Choi","year":"2019","journal-title":"Gigascience"},{"key":"10.1136\/ard-2024-225515_bib25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13742-015-0047-8","article-title":"Second-generation PLINK: rising to the challenge of larger and richer datasets","volume":"4","author":"Chang","year":"2015","journal-title":"Gigascience"},{"key":"10.1136\/ard-2024-225515_bib26","doi-asserted-by":"crossref","first-page":"D988","DOI":"10.1093\/nar\/gkab1049","article-title":"Ensembl 2022","volume":"50","author":"Cunningham","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"10.1136\/ard-2024-225515_bib27","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1136\/ard-2024-225515_bib28","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"10.1136\/ard-2024-225515_bib29","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1136\/ard-2022-223697","article-title":"Identification of new risk loci shared across systemic vasculitides points towards potential target genes for drug repurposing","volume":"82","author":"Ortiz-Fern\u00e1ndez","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2024-225515_bib30","doi-asserted-by":"crossref","DOI":"10.1186\/s12959-015-0047-z","article-title":"Thrombosis in vasculitis: from pathogenesis to treatment","volume":"13","author":"Emmi","year":"2015","journal-title":"Thrombosis J"},{"key":"10.1136\/ard-2024-225515_bib31","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/art.39847","article-title":"Temporal Trends of Venous Thromboembolism Risk Before and After Diagnosis of Giant Cell Arteritis","volume":"69","author":"Unizony","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1136\/ard-2024-225515_bib32","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/rheumatology\/37.2.208","article-title":"Anticardiolipin antibodies in giant cell arteritis and polymyalgia rheumatica: a study of 40 cases","volume":"37","author":"Manna","year":"1998","journal-title":"Rheumatol (Sunnyvale)"},{"key":"10.1136\/ard-2024-225515_bib33","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1053\/sarh.2001.23499","article-title":"Antiphospholipid antibodies and thrombophilic factors in giant cell arteritis","volume":"31","author":"Espinosa","year":"2001","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/ard-2024-225515_bib34","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1136\/annrheumdis-2017-eular.2508","article-title":"AB0552\u2005Antiphospholipid antibodies in giant cell arteritis","author":"Hocevar","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2024-225515_bib35","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2147\/VHRM.S9358","article-title":"Does plasmin have anticoagulant activity?","volume":"6","author":"Hoover-Plow","year":"2010","journal-title":"Vasc Health Risk Manag"},{"key":"10.1136\/ard-2024-225515_bib36","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0955-0674(97)80126-3","article-title":"Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration","volume":"9","author":"Chapman","year":"1997","journal-title":"Curr Opin Cell Biol"},{"key":"10.1136\/ard-2024-225515_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2023.08.011","article-title":"ROS-driven structural and functional fibrinogen modifications are reverted by interleukin-6 inhibition in Giant Cell Arteritis","volume":"230","author":"Bettiol","year":"2023","journal-title":"Thromb Res"},{"key":"10.1136\/ard-2024-225515_bib38","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1038\/s41433-023-02433-y","article-title":"Giant cell arteritis: reviewing the advancing diagnostics and management","volume":"37","author":"Bilton","year":"2023","journal-title":"Eye (Lond)"},{"key":"10.1136\/ard-2024-225515_bib39","doi-asserted-by":"crossref","DOI":"10.1007\/s00330-023-09770-2","article-title":"Orbital magnetic resonance imaging of ocular giant cell arteritis: a systematic review and individual participant data meta-analysis","volume":"33","author":"Guggenberger","year":"2023","journal-title":"Eur Radiol"},{"key":"10.1136\/ard-2024-225515_bib40","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/01.md.0000145369.25558.b5","article-title":"Influence of Traditional Risk Factors of Atherosclerosis in the Development of Severe Ischemic Complications in Giant Cell Arteritis","volume":"83","author":"Gonzalez-Gay","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"10.1136\/ard-2024-225515_bib41","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1136\/annrheumdis-2011-200795","article-title":"Distribution of arterial lesions in Takayasu's arteritis and giant cell arteritis","volume":"71","author":"Grayson","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2024-225515_bib42","first-page":"176","article-title":"High angiopoietin-2 levels associate with arterial inflammation and long-term glucocorticoid requirement in polymyalgia rheumatica","volume":"59","author":"van Sleen","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard-2024-225515_bib43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1006\/scdb.2001.0288","article-title":"The angiopoietins and Tie2\/Tek: adding to the complexity of cardiovascular development","volume":"13","author":"Ward","year":"2002","journal-title":"Seminars in Cell & Developmental Biology"},{"key":"10.1136\/ard-2024-225515_bib44","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1182\/blood-2007-09-113837","article-title":"Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet \u03b1 granules and differentially released","volume":"111","author":"Italiano","year":"2008","journal-title":"Blood"},{"key":"10.1136\/ard-2024-225515_bib45","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/aje\/kws412","article-title":"The table 2 fallacy: presenting and interpreting confounder and modifier coefficients","volume":"177","author":"Westreich","year":"2013","journal-title":"Am J Epidemiol"},{"key":"10.1136\/ard-2024-225515_bib46","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.survophthal.2009.06.008","article-title":"Treatment of nonarteritic anterior ischemic optic neuropathy","volume":"55","author":"Atkins","year":"2010","journal-title":"Surv Ophthalmol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724005594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724005594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard-2024-225515","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T12:33:12Z","timestamp":1762086792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724005594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0003496724005594"],"URL":"https:\/\/doi.org\/10.1136\/ard-2024-225515","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Age, anticoagulants, hypertension and cardiovascular genetic traits predict cranial ischaemic complications in patients with giant cell arteritis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard-2024-225515","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}]}}